Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors.
Boehringer, M., Fischer, H., Hennig, M., Hunziker, D., Huwyler, J., Kuhn, B., Loeffler, B.M., Luebbers, T., Mattei, P., Narquizian, R., Sebokova, E., Sprecher, U., Wessel, H.P.(2010) Bioorg Med Chem Lett 20: 1106-1108
- PubMed: 20031408 
- DOI: https://doi.org/10.1016/j.bmcl.2009.12.025
- Primary Citation of Related Structures:  
3KWJ - PubMed Abstract: 
Synthesis and SAR are described for a structurally distinct class of DPP-IV inhibitors based on aminobenzo[a]quinolizines bearing (hetero-)aromatic substituents in the S1 specificity pocket. The m-(fluoromethyl)-phenyl derivative (S,S,S)-2g possesses the best fit in the S1 pocket. However, (S,S,S)-2i, bearing a more hydrophilic 5-methyl-pyridin-2-yl residue as substituent for the S1 pocket, displays excellent in vivo activity and superior drug-like properties.
Organizational Affiliation: 
F Hoffmann-La Roche Ltd, Pharma Research, CH-4070 Basel, Switzerland.